August 4, 2008

More Trials for Daily HIV Prevention Pill (PrEP)

Researchers in a number of countries are conducting trials and planning others to test whether a daily pill can prevent HIV infections, The New York Times reports (nytimes.com, 8/4).

Pre-exposure prophylaxis (PrEP) is the most promising research in HIV prevention, medical experts say.

“We cannot wait for the study results to begin to prepare for the optimal use and delivery of PrEP,” says Pedro Goicochea, an investigator in a PrEP study under way in Peru and Ecuador. “Instead, we should look ahead to consider all of the possible outcomes of these trials and make real plans for making PrEP available to those who can benefit from it, as quickly and safely as possible if it is proven effective.”

Up to 15,000 people are expected to be participating in trials by mid-2009. Sites of the trials include Botswana, Brazil, Ecuador, Kenya, Malawi, Peru, South Africa, Tanzania, Thailand, Uganda and the United States.

Search: PrEP, trials, prevention

Scroll down to comment on this story.

Previous Comments:

gregory, las vegas, 2008-08-09 00:50:10
whats next? chemotherapy to prevent cancer? you know, for smokers. or maybe we can sell flu shots to healthy people. and if we happen to put something in it that causes a reaction, we can sell them a pill for that too. lots and lots of money to be made from all those healthy people out there who aren't sick with anything. people who trust us without question. out of fear. history shows us this does happen. and people don't think it can ever happen again. to them. but it does. and it has.